Heroin (diacetylmorphine) is a fast-acting, semi-synthetic opioid derived from morphine. It binds to mu-opioid receptors in the brain, producing an intense rush of euphoria followed by sedation. With repeated use, the brain adapts to the drug’s presence — tolerance rises, natural reward pathways are dulled, and the body becomes physically dependent on heroin simply to feel normal.
Clinically, this condition is diagnosed as Opioid Use Disorder (OUD), heroin type, under the DSM-5-TR — a chronic, relapsing brain disease marked by compulsive drug seeking and use despite serious harm to health, relationships, and daily functioning. It is not a matter of willpower; it is a diagnosable medical condition that responds to structured treatment.
Opioid Use Disorder involving heroin; commonly referred to as heroin addiction or heroin dependence
Semi-synthetic opioid
Substance-related and addictive disorder (DSM-5-TR); ICD-11 code for opioid dependence
Opioid dependence, opioid withdrawal syndrome, polysubstance use disorder
Medically supervised detoxification followed by residential or outpatient rehabilitation
No single cause explains heroin addiction. It typically emerges from an interaction of biological, psychological, and social factors — a pattern seen consistently across opioid use disorders. None of these factors makes addiction inevitable, and none should be read as a direct cause on its own; they are associations that raise risk and are useful for early recognition and prevention:
Not every sign will appear in every individual, but the following behavioural, physical, and mental patterns are among the most common indicators of heroin addiction (Opioid Use Disorder involving heroin).
Left untreated, heroin addiction compounds across nearly every domain of life — physical health, mental health, relationships, and financial and legal stability.
Because the body becomes physically dependent on heroin, stopping use triggers a withdrawal syndrome. Opioid withdrawal is generally not life-threatening by itself, but it can be severe, distressing, and difficult to manage without support. Medical assessment matters because of the risks of dehydration, co-occurring illness, polysubstance use, and — critically — the loss of opioid tolerance during abstinence, which raises overdose risk if a person returns to previous levels of use. This is also why unsupervised “cold turkey” attempts so often end in relapse.
Withdrawal timelines vary according to the opioid used, route of use, duration and pattern of use, individual physiology, and other health factors. The stages below are illustrative, not a guarantee of how any individual will experience withdrawal.
Early withdrawal begins — craving, anxiety, and restlessness set in.
Symptoms typically peak — physical discomfort is most intense during this window.
Acute physical symptoms gradually ease under continued clinical support.
Post-acute withdrawal (PAWS) may linger — low mood, poor sleep, and craving that therapy and structure help manage.
Addiction rarely resolves on its own — and the physical and legal risks of heroin use increase with time. It’s time to seek professional help if you notice:
Pinpoint pupils, slow or stopped breathing, blue-tinged lips or fingertips, a limp body, and unresponsiveness are signs of a heroin overdose. This is a medical emergency. Call India’s national emergency helpline (112) or get the person to the nearest hospital immediately. Naloxone is a medicine that can reverse an opioid overdose when given promptly — if it is available and you are trained to use it, administer it while waiting for emergency help, and stay with the person until they receive medical care.
Heroin addiction is treated as a chronic medical condition, not a single event. Withdrawal management on its own does not treat the underlying opioid use disorder — the risk of relapse and overdose can remain high after detox alone. Effective care typically moves through assessment, withdrawal management where indicated, evidence-based medical treatment for OUD, psychological and behavioural therapies, and structured aftercare — combined according to each person’s clinical picture. What is used for any individual is based on clinical assessment, medical history, current use, co-occurring conditions, and treatment goals, as determined by the treating clinician.
A partial opioid agonist that may be considered to reduce cravings and withdrawal, as clinically appropriate for the individual.
A long-acting opioid agonist used, where clinically indicated, as part of structured, supervised treatment for opioid dependence.
An opioid antagonist that may be recommended after withdrawal is complete, for suitable individuals, to help support abstinence.
24/7 clinical monitoring to manage withdrawal safely — the first step toward stabilisation, not a complete treatment in itself.
Medication selection, dosing, and duration are individual clinical decisions made by a qualified physician. Not every medication is appropriate or necessary for every person, and inclusion here does not imply that every listed medication is administered on-site at Thamarai.
Helps identify and restructure the thought patterns and triggers that drive drug-seeking behaviour, replacing them with healthier coping responses.
Builds distress tolerance, emotional regulation, and interpersonal effectiveness — considered where addiction co-occurs with mood instability.
May be used to address trauma that underlies substance use, helping clients reframe unhelpful beliefs formed after traumatic experiences.
Not a first-line treatment for opioid use disorder itself. May be considered under clinical supervision for specific co-occurring psychiatric indications, such as treatment-resistant depression.
Supports repair of relational strain caused by addiction and builds a support system that carries into recovery.
Structured skills training addressing triggers, cravings, and high-risk situations — woven through the programme, not confined to one stage.
A structured residential environment supports recovery by providing routine, distance from prior triggers, consistent clinical monitoring, therapeutic engagement, family involvement where appropriate, and a planned bridge into aftercare. It is the setting within which medical and psychological treatment is delivered, not a replacement for either.
Recovery is individual, and treatment duration varies significantly based on clinical needs. The phases below are illustrative of a broadly common arc — not a guaranteed schedule or a fixed prescription for any individual.
Assessment and medically supervised withdrawal management; stabilisation under 24/7 monitoring, with medical treatment for OUD considered where indicated.
Early therapeutic engagement — CBT/DBT begins, routines and structure are rebuilt.
Core residential programme — individual, group, and trauma-focused therapy deepen.
Structured aftercare, relapse-prevention planning, and step-down support.
Sustained recovery — alumni support, family involvement, and continued check-ins.
Recovery is individual, and treatment duration varies significantly based on clinical needs. The phases below are illustrative of a broadly common arc — not a guaranteed schedule or a fixed prescription for any individual.
A short evaluative stay may be offered to help our clinical team understand a client’s history, severity of use, and co-occurring needs before recommending a full programme. Ask our team whether this applies to your situation.
24/7 clinical monitoring throughout withdrawal, minimising discomfort and managing risk as the body clears heroin from its system — with medical treatment for OUD considered alongside, where indicated.
Length of stay is matched to individual clinical severity and progress — a structured residential environment built around therapy, routine, and rest. Speak with our team for programme duration options.
Medication for OUD where indicated, alongside CBT, DBT, CPT, and other therapies as clinically appropriate — delivered individually and in group settings, with family sessions.
Aftercare planning begins well before discharge, not after — so clients leave with a concrete plan, not just an end date.
Relapse is a common part of many recovery journeys, not a verdict of failure — but a strong prevention plan meaningfully lowers the risk. Ours is built around four pillars:
Identifying the people, places, and emotional states most likely to prompt cravings.
Practical strategies for urge management, distress tolerance, and healthy replacement habits.
Educating and equipping loved ones to support recovery without enabling relapse.
Ongoing check-ins, sober-living guidance, and peer community after discharge.
Thamarai is nestled amidst lush greenery at the foothills of the Anaimalai mountain ranges, in close proximity to the Aliyar riverbank — a private, dignified setting built for individualised Opioid Use Disorder treatment in pollachi
24/7 clinical monitoring throughout withdrawal, minimizing discomfort and risk.
Co-occurring mental health conditions are arrested and treated alongside DUD, not separately.
Every enquiry and admission is handled with discretion, throughout treatment.
Care built around each client's specific history, severity, and circumstances — not a fixed template.
A private, riverside residential environment at the foothills of the anaimalai ranges, designed for calm and focus.
Relapse-prevention and aftercare planning begin before discharge, not after — treatment doesn't stop at the door.
Diagnosis is overseen by our Senior Consultant Psychiatrist, working alongside our Consultant Psychologist, who draws on CBT, motivational enhancement, and insight-oriented therapy for relapse prevention and long-term psychological stability. Every case is reviewed against a full psychiatric picture, not symptoms in isolation.
Speak privately with our clinical team about assessment, treatment options, or admission – no obligation, no judgement.
This page is intended for general informational purposes and does not replace individual medical assessment. Speak with our clinical team for guidance specific to your circumstances.